The Clinical Impact of End-of-Consolidation Measurable Residual Disease in High-Risk Pediatric B-Cell Acute Lymphoblastic Leukemia.
Wang YL, Lee WJ, Chang TY, Hsiao YW et al. • Cancer control : journal of the Moffitt Cancer Center
(2026)
PMC
PMC Public Access (View-Only)
DOI:
10.1177/10732748261495568
PMC: PMC13735454